Profile data is unavailable for this security.
About the company
Bluestar Adisseo Co is a China-based company principally engaged in the research, design, production and distribution of additives for animal nutrition. The Company’s products include functional products, special products and others. Its functional products include methionine, vitamins, ammonia sulfates, as well as sodium sulfates, among others. Its special products include enzyme preparations, organic selenium additives and others. The Company also provides carbon disulfide, sulfuric acid and preparation services. The Company operates its business in domestic and overseas markets.
- Revenue in CNY (TTM)14.95bn
- Net income in CNY1.09bn
- Incorporated1999
- Employees2.73k
- LocationBluestar Adisseo CoNo. 9Beitucheng West Road, Chaoyang DistrictBEIJING 100029ChinaCHN
- Phone+86 1 061958799
- Fax+86 1 061958805
- Websitehttp://www.bluestar-adisseo.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Junshi Biosciences Co Ltd | 1.79bn | -1.80bn | 25.67bn | 2.53k | -- | 4.80 | -- | 14.36 | -1.83 | -1.83 | 1.81 | 6.26 | 0.1593 | 0.8406 | 4.29 | 695,986.10 | -17.55 | -18.87 | -21.98 | -23.11 | 69.07 | 69.13 | -110.18 | -88.41 | 1.75 | -67.73 | 0.3065 | -- | 3.38 | 248.39 | 4.38 | -- | 8.36 | -- |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 9.35bn | 1.14bn | 27.35bn | 8.22k | 24.00 | 3.11 | -- | 2.93 | 0.7772 | 0.7772 | 6.34 | 5.99 | 0.4922 | 1.02 | 3.51 | 1,137,186.00 | 6.01 | 5.67 | 8.37 | 8.07 | 61.97 | 60.52 | 12.21 | 11.61 | 0.7919 | 6.25 | 0.4541 | 33.55 | 0.5199 | 10.28 | -28.88 | 50.51 | 7.21 | -- |
| Kangmei Pharmaceutical Co Ltd | 5.21bn | 255.55m | 28.01bn | 4.41k | 109.07 | 3.98 | -- | 5.37 | 0.0185 | 0.0185 | 0.3766 | 0.5079 | 0.3626 | 1.45 | 2.55 | 1,182,457.00 | 1.80 | -17.60 | 2.77 | -32.24 | 20.63 | -72.78 | 4.95 | -101.19 | 0.8398 | -- | 0.0346 | -- | 16.60 | -22.17 | 103.81 | -22.83 | -53.51 | -- |
| Hubei Jumpcan Pharmaceutical Co Ltd | 8.92bn | 2.78bn | 28.33bn | 5.23k | 10.15 | 2.01 | -- | 3.18 | 3.03 | 3.03 | 9.71 | 15.27 | 0.5135 | 3.08 | 4.60 | 1,706,101.00 | 16.04 | 16.23 | 20.68 | 20.88 | 78.36 | 82.64 | 31.23 | 24.42 | 3.55 | -- | 0.1024 | 41.76 | 7.32 | 6.02 | 30.04 | 10.83 | -14.70 | 1.11 |
| Gan & Lee Pharmaceuticals | 2.95bn | 580.86m | 29.00bn | 4.48k | 49.37 | 2.59 | -- | 9.84 | 0.9773 | 0.9773 | 4.97 | 18.65 | 0.2558 | 0.8458 | 8.94 | 657,602.00 | 5.04 | 8.30 | 5.40 | 8.83 | 72.92 | 85.39 | 19.71 | 26.44 | 6.77 | -- | 0.0005 | 13.65 | 52.31 | 1.78 | 177.37 | -18.30 | 1.50 | -- |
| Bluestar Adisseo Co | 14.95bn | 1.09bn | 30.98bn | 2.73k | 28.42 | 1.96 | -- | 2.07 | 0.4064 | 0.4064 | 5.57 | 5.90 | 0.6887 | 5.18 | 8.01 | 5,466,479.00 | 5.03 | 5.28 | 6.07 | 6.94 | 29.20 | 30.31 | 7.30 | 8.76 | 1.16 | 7.83 | 0.1105 | 21.81 | -9.26 | 2.92 | -95.82 | -43.75 | 2.74 | -19.09 |
| Xiamen Amoytop Biotech Co Ltd | 2.60bn | 740.69m | 31.68bn | 1.96k | 42.77 | 13.99 | -- | 12.21 | 1.82 | 1.82 | 6.38 | 5.57 | 1.08 | 0.8928 | 6.18 | 1,324,099.00 | 30.73 | 17.96 | 35.90 | 21.02 | 92.71 | 90.48 | 28.54 | 19.17 | 3.60 | -- | 0.0044 | 26.95 | 37.55 | 36.19 | 93.52 | 103.28 | 81.61 | -- |
| Humanwell Healthcare Group Co Ltd | 25.56bn | 1.96bn | 34.55bn | 17.68k | 17.47 | 1.93 | -- | 1.35 | 1.21 | 1.21 | 15.87 | 10.95 | 0.6902 | 3.80 | 2.74 | 1,445,825.00 | 7.13 | 6.20 | 13.12 | 12.72 | 45.59 | 42.82 | 10.33 | 9.84 | 1.21 | 12.09 | 0.3171 | 18.87 | 9.79 | 5.65 | -14.07 | -- | 8.25 | -- |
Data as of Sep 13 2024. Currency figures normalised to Bluestar Adisseo Co's reporting currency: Chinese Yuan Renminbi CNY
1.40%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 7.21m | 0.27% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 4.92m | 0.18% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 4.83m | 0.18% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2024 | 4.47m | 0.17% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 3.56m | 0.13% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 2.97m | 0.11% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2024 | 2.46m | 0.09% |
| Mackenzie Investments Corp. (United States)as of 31 Jul 2024 | 2.41m | 0.09% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2024 | 2.40m | 0.09% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2024 | 2.25m | 0.08% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
